Acute graft-versus-host disease: from the bench to the bedside
Authors:
Top Cited Papers
Open Access
- 12 November 2009
- journal article
- review article
- Published by American Society of Hematology in Blood
- Vol. 114 (20) , 4327-4336
Abstract
During the past decade, progress in basic immunology has been impressive. In parallel, whereas our understanding of the pathophysiology of acute graft-versus-host disease (GVHD) has greatly improved, so has our knowledge of the complexities of the immune system. Much of the immunobiology of acute GVHD has been gleaned from preclinical models and far less from correlations with clinical observations or therapeutic interventions. In this review, we summarize some of the major advances in GVHD pathophysiology, including the translation of these from the bench to the bedside, and discuss preclinical approaches that warrant further exploration in the clinic.Keywords
This publication has 141 references indexed in Scilit:
- Graft-versus-host diseaseThe Lancet, 2009
- Human T Regulatory Cell Therapy: Take a Billion or So and Call Me in the MorningImmunity, 2009
- Differential rates of replacement of human dermal dendritic cells and macrophages during hematopoietic stem cell transplantationJournal of Experimental Medicine, 2009
- CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host diseaseNature Immunology, 2008
- Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase–dependent DC functions and regulates experimental graft-versus-host disease in miceJournal of Clinical Investigation, 2008
- Blood-derived dermal langerin+ dendritic cells survey the skin in the steady stateJournal of Experimental Medicine, 2007
- Identification and Characterization of Canine Dendritic Cells Generated In VivoTransplantation and Cellular Therapy, 2007
- An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissuesJournal of Experimental Medicine, 2006
- CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cellsJournal of Experimental Medicine, 2006
- Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cellsJournal of Experimental Medicine, 2006